Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, Anthony V Moorman, Ajay Vora, Martin Zimmermann, Martin Schrappe, Andrea Biondi, Gabriele Escherich, Jan Stary, et al. ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?. Leukemia. 2024. 38. 7. 1477-1487
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al. Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery. 2024
Hisashi Ishida, Toshihiko Imamura, Ryoji Kobayashi, Yoshiko Hashii, Takao Deguchi, Takako Miyamura, Megumi Oda, Masaki Yamamoto, Keiko Okada, Hideki Sano, et al. Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Cancer Medicine. 2024. 13. 12
Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, et al. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Advances. 2023
森本 哲, 塩田 曜子, 坂本 謙一, 工藤 耕, 今村 俊彦, 工藤 寿子. ランゲルハンス細胞組織球症における病態解明と治療の展望-Elucidated pathogenesis and therapeutic prospects in Langerhans cell histiocytosis-第83回日本血液学会学術集会 ; Symposium 2 : Molecular Mechanism of Inflammation and Tumor in Histiocytic Disorders. 臨床血液. 2022. 63. 5. 373-382
森谷 邦彦, 今村 俊彦, 片山 紗乙莉, 戒能 明, 岡本 賢治, 横山 能文, 植村 優, 北澤 宏展, 関水 匡大, 平松 英文, et al. BFM基盤のプロトコールで治療をした日本人小児急性リンパ性白血病における症候性骨壊死の発症率は欧米人と同時である(Incidence of symptomatic ON in pediatric ALL treated with BFM based protocol is similar to children in western countries). 日本小児科学会雑誌. 2022. 126. 2. 294-294
